Highlights
NASDAQ: RGLS       Regulus Therapeutics
Last Price Today's Change   Day's Range   Trading Volume
1.15   -0.01 (0.86%)  1.14 - 1.19  292,074

Overview

 
Avg Volume (4 weeks):1,246,782
4 Weeks Range:1.11 - 1.54
4 Weeks Price Volatility (%):
9.30%
52 Weeks Range:0.42 - 1.54
52 Weeks Price Volatility (%):
65.18%
Average Price Target: 27.00
Price Target Upside/Downside: +25.85

Headlines



No recent Headlines for this stock.


Business Background

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes.

  Be the first to like this.
 
actvtrader I like the 50.00 price target for yahoo!
22/10/2014 3:48 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3426  2837  386  3256 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 AMC 2.871-0.189 
 OBLN 4.03+2.42 
 CLBS 3.95+2.32 
 CTRM 0.321-0.02 
 BNGO 7.928-1.212 
 SNDL 0.698+0.008 
 GEVO 8.52-2.51 
 ADMP 1.289+0.484